NEW COMPOSITIONS OF MEDICINES BASED ON NEW ANTI-POLINERGIC AND INHIBITORS OF EGFR-QUINASA.

摘要

Medication, characterized by a content in one or several anticholinergics of the formula 1 wherein X - means a negatively charged anion once, preferably an anion chosen from the group consisting of chloride, bromide, iodide, sulfate, phosphate, methanesulfonate, nitrate, maleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate and p-toluenesulfonate. in combination with one or several inhibitors of EGFR kinase (2), possibly in the form of their enantiomers, mixtures of the enantiomers or in the form of racemates, possibly in the form of solvates or hydrates, as well as, eventually, together with a pharmaceutically compatible adjuvant.